International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Cancer/Tumor Profiling Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled " Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Fore cast 2022-2027
," the global cancer tumor profiling market reached a value of US$ 9.38 Billion in 2021.
Cancer/tumor profiling, or biomarker testing, is a process of identifying specific proteins, genes, gene mutations (changes), and other biomarkers in a tumor tissue sample. It assists in determining whether the pathways of a tumor match up with the available targeted therapies. It is also used for therapeutic decision-making, routine diagnostics, and personalized treatment plans and therapies based on the severity of the ailment and genomic build-up.
As a result, cancer/tumor profiling finds extensive applications in the discovery of biomarkers, research, personalized medicines, and the development of screening and diagnostic techniques.
Request for a PDF sample of this report:
https://www.imarcgroup.com/cancer-tumor-profiling-market/requestsample
The market is primarily driven by the increasing prevalence of cancer across the globe. In addition, the growing inclination toward personalized medicine among the masses represents another major growthinducing factor. Besides this, governments of numerous countries are investing in cancer research to develop advanced techniques to reduce the time taken for the detection and identification of tumors. This, coupled with the increasing investments by pharmaceutical and biotechnology companies in research and development (R&D) activities for introducing novel therapies and new drug-designing techniques, is positively influencing the market growth.
Furthermore, recent advancements in molecular biology techniques, the rising number of clinical trials, the increasing adoption of immunoassay techniques, and the developing healthcare infrastructure across the globe are some of the other factors creating a positive market outlook across the globe.
Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027, exhibiting a CAGR of 11.20% during the forecast period (2022-2027).
View Report TOC, Figures and Tables: https://www.imarcgroup.com/cancer-tumor-profiling-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Cancer Type:
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma Cancer
• Others
Breakup by Technology:
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
• In-Situ Hybridization (ISH)
• Microarray
• Others
Breakup by Technique:
• Genomics
• Proteomics
• Epigenetics
• Metabolomics
Breakup by Application:
• Personalized Medicine
• Diagnostics
• Biomarker Discovery
• Prognostics
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• Abbott Laboratories
• Becton Dickinson and Company
• Caris Life Sciences
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd
• Hologic Inc
• HTG Molecular Diagnostics Inc
• Illumina Inc
• Laboratory Corporation of America Holdings
• NeoGenomics Laboratories
• Qiagen N.V
• Siemens AG
• Sysmex Corporation
1. What was the size of the global cancer/tumor profiling market in 2021?
2. What is the expected growth rate of the global cancer/tumor profiling market during 2022-2027?
3. What has been the impact of COVID-19 on the global cancer/tumor profiling market?
4. What are the key factors driving the global cancer/tumor profiling market?
5. What is the breakup of the global cancer/tumor profiling market based on the cancer type?
6. What is the breakup of the global cancer/tumor profiling market based on the technique?
7. What are the key regions in the global cancer/tumor profiling market?
8. Who are the key players/companies in the global cancer/tumor profiling market?
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/cancer-tumor-profiling-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
